688050 爱博医疗
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)9.48915.23813.16910.7369.040
总资产报酬率 ROA (%)6.41211.45710.8439.2978.309
投入资产回报率 ROIC (%)7.41913.18212.02010.1996.240

边际利润分析
销售毛利率 (%)69.68476.00584.75484.28983.909
营业利润率 (%)34.59234.42644.74042.71640.746
息税前利润/营业总收入 (%)35.53434.75745.13542.33538.442
净利润/营业总收入 (%)29.04630.07339.21238.73635.202

收益指标分析
经营活动净收益/利润总额(%)98.50295.52491.83589.52494.717
价值变动净收益/利润总额(%)0.0473.5727.03410.4324.604
营业外收支净额/利润总额(%)-0.2740.0671.8221.479-0.196

偿债能力分析
流动比率 (X)3.9152.7087.1858.02414.868
速动比率 (X)3.2492.2286.6517.62214.101
资产负债率 (%)27.61523.05414.44915.0165.547
带息债务/全部投入资本 (%)23.28014.6857.2437.553--
股东权益/带息债务 (%)319.634562.5821,262.5141,206.186-16,478.781
股东权益/负债合计 (%)238.248301.711573.591544.4041,670.179
利息保障倍数 (X)34.254112.932-103.667-41.393-17.287

营运能力分析
应收账款周转天数 (天)74.08259.86353.21359.0300.000
存货周转天数 (天)171.325205.201274.737304.4610.000